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Sphingosine-1-phosphate lyase (SPL), a key enzyme
of sphingolipid metabolism, catalyzes the irrevers-
ible degradation of sphingoid base phosphates. Its
main substrate sphingosine-1-phosphate (S1P) acts
both extracellularly, by binding G protein-coupled
receptors of the lysophospholipid receptor family,
and inside the cell, as a second messenger. There,
S1P takes part in regulating various cellular
processes and its levels are tightly regulated. SPL
is a pivotal enzyme regulating S1P intracellular
concentrations and a promising drug target for the
design of immunosuppressants. We structurally
and functionally characterized yeast SPL (Dpl1p)
and its first prokaryotic homolog, from Symbiobacte-
rium thermophilum. The Dpl1p structure served as
a basis for a very reliable model of Homo sapiens
SPL. The above results, together with in vitro and
in vivo studies of SPLmutants, reveal which residues
are involved in activity and substrate binding and
pave the way to studies aimed at controlling the
activity of this pivotal enzyme.
INTRODUCTION
Sphingolipids are ubiquitous constituents of cell membranes
and their metabolites play the role of signaling molecules in
eukaryotic cells (Hannun and Obeid, 2008). A very important
sphingolipid is sphingosine-1-phosphate (S1P), which acts as
a second messenger and takes part in the regulation of cell
proliferation, motility, invasiveness, and apoptosis (Hait et al.,
2009; Spiegel and Milstien, 2003). The effects of S1P have
been described in a wide spectrum of organisms, ranging from
Arabidopsis thaliana (Dunn et al., 2004; Pata et al., 2009;
Tsegaye et al., 2007), Saccharomyces cerevisiae to Caenorhab-
ditis elegans (Oskouian and Saba, 2004),Mus musculus (Forrest
et al., 2004), and Homo sapiens (Oskeritzian et al., 2007; Rivera
et al., 2008; Saba and Hla, 2004). S1P is unique in that it can act
both as an intracellular second messenger (Hait et al., 2009) and
as a ligand for G protein-coupled cell-surface receptors
belonging to the lysophospholipid receptor family (Hla et al.,
2001; Takabe et al., 2008).1054 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd AThe intracellular levels of S1P are kept under tight control by
three enzymes, the first of which, sphingosine kinase, catalyzes
S1P synthesis, while the other two, sphingosine-1-phosphate
phosphatase and sphingosine-1-phosphate lyase (SPL, EC
4.1.2.27), catabolize it. While sphingosine-1-phosphate phos-
phatase catalyzes the reversible dephosphorylation of S1P,
SPL degrades it irreversibly to phosphoethanolamine (PE) and
hexadecenal (Bandhuvula and Saba, 2007). This complex regu-
lation of S1P levels is biologically very significant in light of the
so-called ‘‘sphingolipid rheostat,’’ whereby cell fate depends
on the ratio of intracellular S1P, which is a proliferative stimulus,
and sphingosine and ceramide, which induce apoptosis (Spiegel
and Milstien, 2003).
Notably, SPL was found to play an important role in regulating
the immune system. Schwab and Cyster (2007) and Schwab
et al. (2005) showed that 2-acetyl-4-tetrahydroxybutylimidazole
(THI), a component of the food colorant caramel III, inhibits
SPL, which normally maintains a steep S1P concentration
gradient between the lymphoid tissues and the vascular circula-
tion. T cells egress from lymphoid tissues by navigating along the
S1P gradient. SPL inhibition by THI leads to disruption of the S1P
gradient, thus preventing the egress of T cells into the blood
stream and causing a logjam in lymphoid tissues (Schwab and
Cyster, 2007; Schwab et al., 2005). There is also evidence of
SPL involvement in tumor-suppressor and cancer surveillance
pathways (Oskouian et al., 2006) and resistance to cisplatin.
Control of SPL expression and activity may prove useful in the
future in adjuvant and reproductive cell-protecting approaches
to cancer therapy (Bandhuvula and Saba, 2007).
SPL belongs to the superfamily of PLP (pyridoxal 50-phos-
phate)-dependent enzymes. Its activity was first characterized
more than 40 years ago (Stoffel et al., 1968); more recently, the
genes for C. elegans (Mendel et al., 2003), yeast (Saba et al.,
1997), mouse (Zhou and Saba, 1998), plant (Nishikawa et al.,
2008), and human SPL (Van Veldhoven et al., 2000) were cloned.
To date, there is scarce data about the structure and biochem-
istry of SPL. The enzyme is known to be located in the ER
(endoplasmic reticulum) and to possess an N-terminal lumenal
domain, a transmembrane segment and a soluble PLP-binding
domain, responsible for the catalytic activity (Ikeda et al., 2004;
Van Veldhoven and Mannaerts, 1991).
The biological relevance and the growing amount of interest
around SPL as a drug target (Bandhuvula and Saba, 2007; Fyrst
and Saba, 2008; Han et al., 2009; Kumar and Saba, 2009)
mandated, as the next step, high-resolution structural character-
ization of this enzyme, which had to date been shown to existll rights reserved
Table 1. Data Collection and Refinement Statistics for the Structures St_1-4 and Dpl1p
Structure code St_1 St_2 St_3 St_4 Dpl1p
Space group P212121 P212121 C2221 P212121 F222
Unit cell parameters (A˚) a = 57.6
b = 126.8
c = 137.1
a = 84.2
b = 84.9
c = 131.3
a = 64.4
b = 243.4
c = 280.7
a = 57.7
b = 127.0
c = 136.8
a = 151.1
b = 156.9
c = 201.6
Number of polypeptide chains per a.u. 2 2 4 2 2
Resolution rangea (A˚) 29.5–2.0
(2.1–2.0)
30.0–2.97
(3.10–2.97)
29.9–2.9
(3.0–2.9)
30.0–2.05
(2.2–2.05)
48.0–3.15
(3.32–3.15)
Completenessa (%) 98.8 (98.6) 98.7 (92.8) 97.6 (92.7) 98.9 (95.0) 99.9 (100.0)
Redundancy 4.4 5.4 6.0 6.7 6.5
Unique reflections 67,856 19,779 48,405 63,157 20,848
I/s a 9.6 (2.5) 13.7 (4.3) 11.9 (2.8) 16.4 (4.5) 15.1 (2.6)
Rsym
a (%) 9.2 (60.3) 11.0 (44.2) 12.6 (57.9) 7.9 (43.1) 8.7 (70.7)
No. of reflections (test) 67,794 (950) 19,768 (988) 48,401 (2420) 63,122 (875) 20,686 (610)
No. of atoms 7268 6480 13845 7478 6634
Rwork (%) 21.0 20.0 22.9 18.1 24.1
Rfree (%) 24.7 26.5 25.2 21.8 30.0
rmsd bonds (A˚) 0.005 0.006 0.005 0.007 0.002
rmsd angles () 0.98 0.97 0.96 1.09 0.52
NCS restraints applied No Yes Yes No Yes
Ramachandran plot regions (MolProbity)
Favored (%) 97.5 95.4 96.7 97.8 92.3
Allowed (%) 100.0 99.9 100 100 99.0
Number of outliers 0 1 (K311 B) 0 0 8b
See also Table S2.
a Values for the outermost resolution shell in brackets.
b S233, G312, S347, G415 in each of the two chains.
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Pro- and Eukaryotic Sphingosine-1-Phosphate Lyaseonly in eukaryotes. To this end, we first used a bioinformatically
identified putative prokaryotic homolog, the product of gene
STH1274 from the commensal thermophilic bacterium Symbio-
bacterium thermophilum (Ueda et al., 2004), whichwe character-
ized as a bona fide sphingosine-1-phosphate lyase and named
StSPL. This in turn allowed us to solve the structure of Saccha-
romyces cerevisiae SPL, called Dpl1p, and obtain a reliable
homology model of the human counterpart, SPL. Both StSPL
and Dpl1p exhibit flexible stretches in regions surrounding the
active site. These flexible regions carry crucial residues for
activity, as shown by our thorough mutagenesis-based func-
tional analysis. Altogether, our structural and functional studies
of StSPL andDpl1p allowed us to propose a reactionmechanism
for the cleavage of long-chain base phosphates by SPL.
RESULTS AND DISCUSSION
Structure of Full-Length StSPL: Symmetries
and Asymmetries
In a previous study (Mukhopadhyay et al., 2008), we had
described a parsed homology model of the active site of
Dpl1p, based on the active site of Escherichia coli glutamate
decarboxylase (GadB) (Capitani et al., 2003; Gut et al., 2006),
which shares 23% sequence identity with Dpl1p over a 251
residue stretch. Mutations based on that limited model and
assumed to influence the enzyme activity were confirmed by
cell biology data (Mukhopadhyay et al., 2008). As the nextStructure 18, 1054–step, we embarked on a structure determination program,
encompassing not only Dpl1p but also a putative prokaryotic
SPL homolog in Symbiobacterium thermophilum (Uniprot code
Q67PY4), which we had identified by a BLAST search (Altschul
et al., 1997) of Dpl1p taxonomically limited to prokaryotes and
named StSPL. We cloned the gene encoding Q67PY4 from the
genome of S. thermophilum, expressed it in E. coli, and obtained
pure protein and diffraction-quality crystals. The structure of
StSPL was solved first, with a molecular replacement approach.
A dimer from the GadB hexamer was used as the search model.
Two StSPL structures were refined at 2.0 and 3.0 A˚ resolution
(Table 1), respectively, from two different crystal forms, the
first (St_1) (Figure 1A) containing a symmetric StSPL dimer in
the asymmetric unit (a.u.), the second (St_2) (Figure 4) also con-
taining one dimer per a.u. but featuring clear conformational
asymmetry between subunits A and B. The asymmetry was not
only limited to the protein chains but involved cofactor binding
as well. While in St_1 both active sites contain a PLP molecule
covalently bound to K311 to form an internal aldimine, in St_2
one active site is PLP-free and contains a phosphate ion at
the place of the cofactor phosphate moiety (Figure 4B). The
following structural description of the StSPL structure refers to
St_1 (Figure 2A): each subunit can be divided into a N-terminal
disordered region (called hereafter Nt-FLEX), spanning residues
1–57 and corresponding to absent or poor electron density, and
a folded core encompassing residues 58–507. The core exhibits
a typical type 1 PLP-dependent enzyme fold, attributed by the1065, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1055
Figure 1. Cartoon Representation of FL WT
StSPL (Structure St_1) and Dpl1p D1-102
(Structure Dpl1p-S)
(A) Subunit A of St_1 appears in light gray, subunit
B in dark gray. The cofactor (PLP) and phosphate
ion of both subunits, together with the covalently
bound side chain of K311 (see Figure 2), are in
ball-and-stick representation in the color of the
respective subunit and atom colors. Nt-FLEX (resi-
dues 1–57) is not visible and its end is represented
by dashed lines in the color of the corresponding
subunit. The N and C termini of each subunit are
indicated.
(B) Subunit A of Dpl1p-S is in green, subunit B in
dark brown. Color coding is as above. StSPL
K311 corresponds to Dpl1p K380. The end of Nt-
FLEX (corresponding to residues 103–130) and
stretches 541–563, as well as residues 580–589,
are represented by dashed lines of the color of
the corresponding subunit. All structural figures
were prepared with PyMOL (DeLano, 2002).
Structure
Pro- and Eukaryotic Sphingosine-1-Phosphate LyaseSCOP database (Andreeva et al., 2008) to the pyridoxal-depen-
dent decarboxylases subfamily. Its closest structural relative
is GadB, with a rmsd of 2.2 A˚ over 363 common Ca atoms. The
StSPL core can be divided into an N-terminal domain (residues
58–97), a large domain containing the cofactor binding K311
(residues 98–382) and a small C-terminal domain (residues
383–471). This domain structure is common with pyridoxal-
dependent decarboxylases like GadB. StSPL, however, pos-
sesses a fourth C-terminal domain, dubbed C-terminal exten-
sion (Ct-EXT, residues 472–507).
Structure of Dpl1p D1-102: Similarities and Differences
to StSPL
Using the structure of the K311A StSPL mutant (Bourquin, 2010)
(at the time it was the highest quality structure of StSPL available)
as search model, we could solve and refine the structure of
Dpl1p D1-102 at 3.15 A˚ resolution (Table 1) (space group F222,
with two Dpl1p D1-102 subunits per a.u., creating two different
dimers by crystallographic symmetry). The use of a high-
resolution, well-refined model of StSPL was instrumental to
locating the two Dpl1p D1-102 subunits with Phaser (McCoy,
2007). The solution found refined well in Phenix (Zwart et al.,
2008). The two refined Dpl1p D1-102 dimers are conformation-
ally very similar but differ by cofactor binding, since one of
them (Dpl1p-S) contains PLP in both active sites (Figure 1B),
while the other (Dpl1p-A, mainly apo) exhibits very low occu-
pancy of the cofactor (not modeled) (Figure 3A). As in subunit
B of St_2 (Figure 4B), the missing cofactor is partly replaced by
a phosphate ion.
The overall structure of Dpl1p D1-102 is very similar to that of
StSPL, with a rmsd between the Dpl1p-S and St_1 dimers of
1.2 A˚ over 399 common Ca atoms (Figure 3B) and of 1.2 A˚
over 396 common Ca atoms between the Dpl1p-A and St_1
dimers and 42% sequence identity. Notably, even though the
Nt-FLEX of StSPL and Dpl1p differ substantially, with the latter
containing a predicted lumenal domain, followed by a transmem-1056 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd Abrane region and a cytoplasmic spacer (Figure 7A), their end is
spatially very well conserved: the observed folded core of
Dpl1p D1-102 starts with residue N131, superimposing well
onto residue K58 of St_1 (Figure 3B). The same degree of
conservation is observed also with respect to the domain struc-
ture. In the folded core of Dpl1p D1-102, the N-terminal domain
spans residues 131–167, the large domain containing the
cofactor-binding K380 extends from 168 to 451, the small
domain from 452 to 540 and the Ct-EXT from 541 to 589 (Fig-
ure 2B). The only significant structural difference between St_1
and Dpl1p D1-102 resides in Ct-EXT, where Dpl1p-S residues
541 to 563 (566 in Dpl1p-A) and 580 to 589 are conformationally
disordered and correspond to absent or very poor electron
density (Figures 1B, 2B, 2D, and 3). This difference appears to
have important functional implications as Dpl1p D1-102 was
found to be inactive in vitro (see section on activity andmutagen-
esis studies) even though its boundaries correspond perfectly to
those of the folded core of StSPL (Figure 3B), which is active
in vitro. Since full-length (FL) Dpl1p is active in vivo (Figure 7B),
we assume that Nt-FLEX (residues 1–130) plays a key role for
activity, presumably in substrate presentation to the active site,
and the absence of its first 102 residues may be correlated
with the disorder of Ct-EXT. This is corroborated by the observa-
tion that in StSPL residues 473–488 constitute the ‘‘bottomwall’’
of a long hydrophobic pocket adjacent to the active site, which is
not present in GadB and most likely accommodates the long
hydrophobic chain of the substrate before its entrance into the
active site (Figure 2C). In the crystal structure of Dpl1p D1-102
the aforementioned hydrophobic pocket lacks the ‘‘bottom
wall’’ (Figure 2D) since residues 541–563 are disordered.
The Region around the Active Site in StSPL: More
Asymmetries and Comparison to Other Enzymes
As mentioned above, the St_2 structure of FL WT (wild-type)
StSPL exhibits clear asymmetries between subunits A and B,
in contrast to the symmetry shown by the St_1 dimer. Thell rights reserved
Figure 2. Subunit Structure and Domains of
StSPL and Dpl1p D1-102
(A) Cartoon representation of subunit A of FL WT
StSPL (structure St_1). The cofactors, together
with the covalently bound side chain of K311 (in
StSPL) and K380 (in Dpl1p), appear as described
in Figure 1. The end of Nt-FLEX is depicted as
dotted green line; the N-terminal domain is
colored green, the large domain white, the
C-terminal domain beige and Ct-EXT blue. The
b-hairpin of subunit A, covering the active site of
subunit B (not shown), is boxed with a dashed line.
(B) Cartoon representation of subunit A of
Dpl1pD1-102 (structure Dpl1p-S). Details as in (A).
(C and D) Surface representation of StSPL (struc-
ture St_1) and Dpl1p D1-102 (structure Dpl1p-S)
showing the active site entry channel. (C) Subunit
A of St_1. The N-terminal domain is colored green
while Ct-EXT is colored blue. The first histidine of
the C-terminal His-tag is labeled. K311, PLP, and
phosphate ion are shown as sticks. (D) Subunit A
of Dpl1p-S. Color coding is as in (C).
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B but involve the protein conformation around the active site
(Figure 4): while in subunit A the regions surrounding the active
site are ordered and a chloride ion is found at the position occu-
pied by a phosphate ion in St_1 (Figure 2A), in subunit B no chlo-
ride or phosphate ion is observed and the loop comprising resi-
dues 90–107 is mostly disordered, with only residues G102 to
Y105 corresponding to interpretable density (Figure 4B). The
Ct-EXT of subunit A is again partly disordered, with only residues
475–483 and 490–507 corresponding to interpretable density.
The entire Ct-EXT of subunit B is disordered. As a consequence,
the hydrophobic pocket of subunit B of St_2 partly lacks its
‘‘bottom wall’’ (Figure 2C), while its counterpart in subunit A is
nearly complete since its Ct-EXT is partly ordered. Yet another
element of asymmetry in St_2 is the S123*-S135* loop (residues
followed by an asterisk belong to the neighboring subunit),
exhibiting markedly higher B-factors in chain A (lining the active
site of subunit B) than in chain B (<B > = 60 A˚2 in the former
versus 41 A˚2 in the latter).
Crystallographic and biochemical studies of the two isoforms
of human glutamate decarboxylase, GAD65 and GAD67 (Fenalti
et al., 2007), showed the importance of a ‘‘catalytic loop’’ (resi-
dues 432*–442* in GAD67) being ordered or disordered for the
control of enzyme activity. The active site loop of human GAD
is not conserved in SPL, where it is replaced by a b-hairpinStructure 18, 1054–1065, August 11, 2010 ª(residues 334*–349* in StSPL) (Figure 2A),
but it suggests a functional role for the
aforementioned asymmetric elements of
St_2, all of which are located nearby.
Another enzyme involved in sphingoli-
pid metabolism, serine palmitoyl-trans-
ferase (SPT), exhibits peculiar asymmetry
with respect to PLP binding: it is a hetero-
dimer composed of two strictly related
subunits plus a third subunit conferring
substrate specificity (Han et al., 2009;
Hornemann et al., 2009). One of the twosubunits of the heterodimer lacks the residues for PLP binding
even though it is required for activity, as modeled from the struc-
tures of Sphingomonas paucimobilis (Yard et al., 2007) and
Sphingobacterium multivorum (Ikushiro et al., 2009) SPTs. St_2
features asymmetry in cofactor binding in spite of being a homo-
dimer. Modulation of cofactor binding thus appears to be a
feature common to several eukaryotic PLP-dependent enzymes.
Altogether, our structural studies of StSPL and Dpl1p D1-102
reveal that both proteins share the same fold and that the
disorder in the N terminus (Nt-FLEX domain) is a conserved
feature. Moreover, variations are found in the cofactor occu-
pancy in some forms of both enzymes. One significant difference
between StSPL and Dpl1p D1-102 is that the latter lacks part of
Ct-EXT covering the active site. Asymmetries between both
subunits of one crystal form of StSPL were mapped in three
regions surrounding the active site. We assumed that this flexi-
bility is functionally relevant and performed mutagenesis studies
of residues carried by these loops (see below).
Cofactor Binding Mode and Active Site in FL StSPL and
Dpl1p D1-102 and Model of Substrate Accommodation
The cofactor binding mode and the active site in general are
very well conserved between StSPL and Dpl1p: in both cases
the phosphate moiety of PLP is held in place by a classical
‘‘phosphate cup’’ motif (Denesyuk et al., 2003) with residues2010 Elsevier Ltd All rights reserved 1057
Figure 3. Dpl1p-A, Dpl1p-S and StSPL
(A) Cartoon representation of Dpl1p-A dimer.
Subunit C appears in green, subunit D in dark
brown. Color coding is as in Figure 1.
(B) Superposition, in cartoon representation, of the
Dpl1p-S dimer structure onto StSPL (structure
St_1). The color coding is as in Figure 1. The first
ordered residue of each protein (K58 for StSPL
and N131 for Dpl1p-S) is denoted by an arrow.
Structure
Pro- and Eukaryotic Sphingosine-1-Phosphate Lyase(StSPL numbering) G168, T169, H310, and S353* hydrogen-
bonding the phosphate oxygen atoms (see Figures S1A and B
available online). The pyridinium ring of PLP is sandwiched
between residues C276 and H201 in StSPL, corresponding to
residues C344 and H268 in Dpl1p. Another common feature is
a phosphate ion found at the same position in both proteins, in
the vicinity of the cofactor. The ion interacts with the phenolic
moiety of Y105, the imidazolium ring of H129*, the main chain
amide nitrogen of A103 and the carboxamide group of N126*
(distances 2.6, 2.7, 2.8, and 3.2 A˚, respectively, in subunit A of
St_1). The corresponding phosphate-binding residues in the
active site of Dpl1p are Y174, H198*, and A172. The conserved
binding mode of the phosphate ion mimics the binding mode
of the phosphate moiety of the natural substrate of the enzyme,
S1P. This is confirmed by the structure of StSPL K311A in
complex with the product PE at 2.9 A˚ resolution (structure
St_3) (Table 1; Figure 5A). PE is one of the two products of the
SPL reaction and contains the polar part of the substrate. No1058 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd All rights reservedsignificant conformational changes were
observed between St_1 and St_3 (rmsd
value of 0.3 A˚ over 446 common Ca
atoms). PE was seen to form a Schiff
base with PLP and its phosphate group
replaced the phosphate ion found in the
active sites of St_1 and Dpl1p D1-102
(Figures 2A and 2B). Based on St_3, we
modeled the substrate S1P bound in
WT StSPL (Figure S1C) and carried out
mutagenesis studies on residues A103,Y105, H129*, C276, K311, K317, and Y482 (Figure 5B). The
mutants were designed on the basis of the well-described
biochemistry of PLP-dependent enzymes (Eliot and Kirsch,
2004; Toney, 2005) as well as by taking into account the mech-
anism proposed in Van Veldhoven and Mannaerts (1993) and by
assuming that residues found in flexible stretches of Dpl1p
D1-102 and St_2 (Figures 2B and 2D, and Figure 4, respectively)
might be involved in activity (see previous sections). Residues
A103 and Y105 (StSPL numbering) are located on the active-
site flanking loop that is disordered in subunit B of St_2 (Figure 4,
dark brown loop). H129* and K317 sit near the phosphate moiety
of the active site-bound substrate, even though K317 is too
distant (nearly 5 A˚) to hydrogen-bond the phosphate. In an early
study of SPL (Van Veldhoven et al., 2000), the residue corre-
sponding to C276 had been proposed to be the nucleophile
required for bond cleavage and was therefore included into our
mutagenesis study. The activity of mutants of the corresponding
residues in Dpl1p (A172, Y174, H198*, C344, K380, K386, andFigure 4. Cartoon Representation of the
Two Subunits of the Asymmetric Form of
StSPL (Structure St_2)
(A) Subunit A appears in light gray with the
same color conventions as in Figure 1. Addition-
ally, structural elements exhibiting asymmetry
between the two subunits of St_2 are depicted
as follows: residues A89–D108 in brown, P472–
V507 (Ct-EXT) in blue, and K58–F64 in green.
The chloride ion bound in the active site of subunit
A is shown in beige in space-fill model. The loop
S123*–S135*, which completes the active site
environment, is colored according to its B-factors
(blue corresponds to lower B-factors). Disordered
regions are represented by dashed lines.
(B) Same as above with view vertically rotated by
180 and focusing on subunit B. The active site
lacks the cofactor (the trace of PLP in the subunit
A is depicted by a red dashed line), which is partly
replaced by a phosphate ion.
Figure 5. Close-up View of the Active Sites of StSPL and Dpl1p D1-102
(A) Stereo representation of the reaction product PE bound to PLP (PLP-PE) in the active site of StSPL K311A (structure St_3). Color coding is as in Figure 1A.
(B) Same as (A), showing themodeled external aldimine intermediate with S1P (PLP-S1P). Color coding is as in Figure 4. The residues studied bymutagenesis are
labeled. The model, based on the structure of St_3, is to be considered tentative, especially with respect to the C2-C3 (see Figure 8, step II) torsion angle and to
the conformation of the hydrophobic chain. The optimal conformation for retro-aldol cleavage is with the C3-hydroxyl moiety of S1P antiperiplanar to the amino
group of the aldimine (Dunathan, 1966). In our modeling attempt, such a conformation led to steric clashes with Y249 (Figure S1C).
(C) Stereo representation of a superposition of Dpl1pD1-102 (Dpl1p-S) onto FLWT StSPL (structure St_1), showing the residues of Dpl1p presumably involved in
activity. Color coding is as in Figure 1. See also Figures S1 and S2.
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Figure 6. Spectrophotometric Activity
Assay of StSPL Using S1P As Substrate
(A) FL WT control for (B) and (C). The visible spec-
trum (320–500 nm) of the enzyme before and after
addition of substrate is depicted by a dotted and
a solid line respectively. Spectra were recorded
each min over 5 min. The transient peaks at 403
and 420 nm as well as changes in the 450 nm
regions are indicated with arrows.
(B) Same as (A) for K311A.
(C) Same as (A) for Y105F.
(D) Same as (A) for Y482F except that the spectra
were recorded during 30 min. FL WT control is
shown in (F).
(E) C276A. FL WT control is shown in (F).
(F) FL WT control for (D) and (E). Spectra of (E) and
(F) were recorded as in (D). See also Figures S3,
S4, and S5.
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Pro- and Eukaryotic Sphingosine-1-Phosphate LyaseY554) was compared using an in vivo assay (Mukhopadhyay
et al., 2008). The active sites of St_1 and Dpl1p-S superimpose
very well and the above-mentioned residues occupy structurally
equivalent positions in both enzymes, except for Y554 (Y482
in StSPL), which is found in the disordered region of Ct-EXT of
Dpl1p (Figure 5C).
Importantly, Dpl1pD1-102 shares 45% sequence identity over
420 residues with its medically important human counterpart,
SPL (UniProt code O95470): we could calculate a reliable
homology model of SPL (Figure S1D), showing that the active
site is conserved between the two proteins, with the exception
of T148 in SPL (A172 in Dpl1p). A multiple sequence alignment
of StSPL, Dpl1p and SPL with the predicted secondary structure
elements can be found in Figure S2. The structural features and
the functionally important residuesdescribed in this studyprovide
a solid basis for futuremutagenesis and inhibition studies of SPL.
Activity and Mutagenesis Studies
of StSPL and Dpl1p
The visible spectrum of FL WT StSPL exhibits a shoulder at
340 nm and a broad peak at 420–460 nm, presumably resulting
from the contribution of two species centered at 425 and 450 nm
(Figure 6A, dotted line), respectively. The 340 and 425 nm
species correspond to tautomers of the internal aldimine (Gut
et al., 2009), while the 450 nm band represents an unknown1060 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd All rights reservedspecies. The spectra of mutants K311A
and C276A (Figures 6B and 6E, dotted
lines) and of construct DCt-EXT (lacking
residues 472–507) (Figure S3B, dotted
lines) differ markedly from that of FL WT.
They feature a peak at 345 nm, which
may correspond to the hydrated form of
PLP, as seen in the structure of StSPL
K311A (Bourquin, 2010).
Mutagenesis studies were carried out
on the residues listed above as well as
on Nt-FLEX and Ct-EXT truncation vari-
ants of StSPL (Figure 2A). There are
many SPL activity assays available,
based on the detection of fluorescentspecies (Bedia et al., 2009; Bandhuvula et al., 2007, 2009). In
the present work, the activity of StSPL mutants and variants
compared with FL WT was assessed by spectrophotometry
and mass spectrometry (MS). The first method monitors varia-
tions occurring in the environment of PLP upon catalysis, as
shown for serine palmitoyltransferase (Ikushiro et al., 2009;
Raman et al., 2009; Shiraiwa et al., 2009), and thereby indirectly
monitors the activity of the protein, while the latter monitors
substrate cleavage. Both tests provided qualitative information.
Quantitative analysis was hindered by variations in the amount of
soluble material, presumably due to discrepancies in the purity
of S1P from various batches of chemical synthesis or of extrac-
tion from natural sources, to the inherently poor solubility of S1P
(Garcı´a-Pacios et al., 2009) and to the challenging reproducibility
of the solubilization procedure, as well as by variations when de-
salting the sample before MS. As a consequence, an accurate
concentration of S1P was difficult to obtain, resulting in different
response intensities in the activity assays. Therefore, the activity
of mutants or variants of StSPL has to be compared with that of
the FL WT StSPL purified in parallel and tested under similar
conditions.
The spectrophotometric activity assay monitors the appear-
ance and disappearance of transient peaks at 403 and 420 nm,
accompanied by a decrease in the absorption at 450 nm, that
appeared upon mixing FL WT StSPL with S1P (Figures 6A
Figure 7. Function of Dpl1p Variants In Vivo
(A) Proposed arrangement of the catalytic domain of Dpl1p with respect to the ER membrane. The two subunits are depicted as in Figure 1B. TMH, transmem-
brane helix.
(B) Yeast strain RH4863 carrying FL WT Dpl1p, Dpl1p D1-57, FL mutants A172P, Y174F, H198A, C344A, K380A, K386A, and Y554F or an empty vector (desig-
nated dpl1pD) were 5-fold serially diluted and spotted onto SD plates without leucine or on SD plates with uracil and 5-fluoroorotic acid (5-FOA). Only strains
carrying a functional Dpl1p can grow in presence of 5-FOA (Mukhopadhyay et al., 2008). The colonies were photographed after 3 days of incubation at 30C.
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Pro- and Eukaryotic Sphingosine-1-Phosphate Lyaseand 6F; Figures S3C and S3G), dihydrosphingosine-1-phos-
phate (DHS1P) (Figure S3H) or phytosphingosine-1-phosphate
(PS1P) (Figure S3I). We tentatively interpret those peaks as the
external aldimine species PLP-S1P and PLP-PE (Figure 8, steps
III and VII). The 420 nm band may correspond to the external
aldimine with PE, since a spectrum of StSPL K311A incubated
with PE shows a slowly appearing, broad band centered at
about 425–430 nm (Bourquin, 2010). It is noteworthy that no
similar changes were observed upon incubating StSPL WT and
PE (Bourquin, 2010). The above transient spectrophotometric
changes correlate with the cleavage of S1P, as shown by MS
(Figures S4C and S4D). The time elapsed until disappearance
of the peaks (relaxation time) is assumed to be proportional to
the amount of enzyme and its degree of activity. When FL WT
StSPLwas incubatedwith semicarbazide, a general PLP-depen-
dent enzyme inhibitor, the 420–460 nm peak disappeared and
was replaced by a 360 nm peak with a clear isosbestic point
(Figure S5C), and only very faint transient peaks were observed
upon substrate addition (Figure S5D). The PLP-semicarbazone
adduct (Figure S5B) formed by the inhibitor with the cofactor
was found by crystallography (structure St_4) to have left the
active site (Figure S5A). This correlates with the observation
that cocrystals of StSPLwith 10-foldmolar excess of semicarba-
zide are colorless, while the native crystals are bright yellow
(Bourquin, 2010). In St_4, the nearby residue Y249 (Figure S1C)
partly replaces the pyridinium ring of the PLP but is likely not
involved in catalysis, since mutant Y249F behaves similarly as
FL WT (Figures S5E and S5F, respectively). StSPL mutants
K311A and Y105F did not exhibit significant time-dependent
changes in the spectrophotometric (Figures 6B and 6C, respec-
tively) and MS (Figures S4H and S4I, respectively) assays and
were categorized as inactive. Mutants A103P and K317A
(Figures S3E and S3F, respectively) exhibited no transient peaks
at 403 and 420 nm and no activity in the MS assay (Figure S4JStructure 18, 1054–and S4K, respectively). All the above mutants were categorized
as inactive. StSPL Y482F, C276A (Figures 6D and 6E, respec-
tively), H129A and DCt-EXT (Figures S3D and S3B, respectively)
exhibited a significantly longer relaxation time and much less
intense transient peaks (especially for H129A) and were thus
assumed to be partly active. StSPL DNt-FLEX behaved similarly
(albeit with an altered relaxation time) as FLWT (Figure S3A). The
Dpl1p truncation D1-102 used for structure determination did
not exhibit any visible spectrum alterations upon addition of
S1P, DHS1P nor PS1P (Figures S3J, S3K, and S3L, respectively)
and was therefore considered as inactive in vitro.
The Nt-FLEX of FL Dpl1p (residues 1–130) is assumed to
consist, from its N to C terminus, of a lumenal domain (residues
1–57), a transmembrane helix (residues 58–82), a linker and
a spacer (Figure 7A). A yeast synthetic lethality test (Mukhopad-
hyay et al., 2008) was used to assess the activity of mutants and
of the lumenal domain truncation of Dpl1p. Dpl1p D1-57 and FL
Dpl1p Y174F, H198A, Y554F are partly active, C344A is probably
slightly less active as the WT, while K380A, A172P, and K386A
are inactive (Figure 7B). The mutagenesis results of Dpl1p are in
good agreement with those of StSPL, except for Y174F
(corresponding to StSPL Y105F). This single difference might
arise from the very different time scale of the in vitro experiments
compared with the in vivo experiments or from other sources of
bias. For instance, we do not know which enzymatic parameters
(Km, Kcat) aremost crucial for the in vivo experiment. Alternatively,
the precise role of this residue might not be conserved between
StSPL and Dpl1p, as a result of different modes of regulation.
Importantly, Y174 of Dpl1p is conserved in SPL (Y150). Dpl1p
Y174F was found to be partly active: a possible role for this
residue is that of influencing the protonation state of K386 and
this might represent a regulation mechanism of eukaryotic SPLs.
Further analysis is required to confirm that StSPL Y105F is fully
inactive since our in vitro assays are not quantitative. Based on1065, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1061
Figure 8. Proposed Mechanism of S1P Cleavage by SPL
The incoming S1P (step II) replaces the catalytic lysine (311 in StSPL and 380 in Dpl1p) as Schiff base partner of PLP, forming an external aldimine (step III). Retro-
aldol cleavage occurs at the hydroxyl group of carbon atom 3 of S1P (step III) and the long-chain aldehyde product (called hexadecenal in case S1P is the
substrate) is released (step IV). The second external aldimine (step VII) results from reprotonation (step VI) of the quinonoid intermediate (step V). PE is then
released (step VIII) and the internal aldimine is re-formed (step I): the enzyme is now ready for a second turnover.
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H129*, found close to the phosphate head of the substrate, are
important for substrate binding. The side-chain amino group of
K317 is also close to the phosphate location but not within
hydrogen-bonding distance (4.8 A˚ in St_1, subunit A). A103
appears to keep the loop 89–108, containing Y105 (Figure 4A,
dark brown), in a conformation able to bind the phosphate
moiety of the cofactor. The corresponding residue of SPL,
T148, might provide additional stabilization by interacting with
H174* and N171* (Figure S1D).
Figure 8 summarizes the reaction mechanism we propose
based on the structural, biochemical and literature information
available. Step III is a retro-aldol cleavage whereby a base
(depicted as B:) nucleophilically attacks the proton of the
hydroxyl moiety of the substrate. Based on our current model
of the external aldimine with S1P (Figure 5B) the identity of that
base is not clear and its elucidation will require further structural
and biochemical studies. Notably, for serine hydroxymethyl-
transferase, another PLP-dependent enzyme catalyzing
a retro-aldol cleavage, finding the corresponding base has
proved similarly difficult (Schirch and Szebenyi, 2005). The1062 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd Aquinonoid reprotonation step (step VI), resulting in the formation
of the external aldimine PE-PLP and in the subsequent release of
PE (steps VII and VIII, respectively) may be carried out by StSPL
K311 or by the nearby Y105 (K380 and Y174 in Dpl1p, K353 and
Y150 in SPL). K317 of StSPL (K386 in Dpl1p and K359 in SPL) for
sure electrostatically contributes to the binding of the phosphate
moiety of the substrate and may also play an indirect role in the
reprotonation. The partial activity of the alanine mutant of C276
(C344 and C317), a PLP stacking residue, indicates that its role
is mostly structural, keeping the cofactor in an optimal position
for reactivity. This is consistent with the observation that the
side chain thiol of C276 points away from the substrate instead
of toward it. Y482 (Y554 and Y526) appears to play an important
role in activity, possibly in substrate accommodation since it
belongs to the ‘‘bottom wall’’ region discussed above. Further
analysis is required to decipher the precise role of all residues
involved in the reaction mechanism of SPL.
As mentioned above, the extent of disorder or flexibility of
the N termini (Nt-FLEX) seems to be conserved from StSPL to
Dpl1p D1-102 (Figure 3B) and may reflect a functional role,
presumably in accommodating the substrate embedded inll rights reserved
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precise mechanism of accommodation is most probably not
conserved, because StSPL DNt-FLEX behaves as FL WT in
the in vitro activity test (Figure S3A), and Dpl1p D1-102 is
inactive in vitro, while Dpl1p D1-57 is only partly active in vivo
(Figure 7B).
The N and C termini of StSPL, and most probably of Dpl1p,
surround the active site entry channel (Figures 2C and 2D,
respectively) and might act as a gate that isolates the sub-
strate-bound active site from solvent and thus promotes catal-
ysis. Indeed, StSPL DCt-EXT appears to be less active than FL
WT StSPL (Figure S3B).
Our functional analysis of StSPL and Dpl1p clearly indicates
that the flexible regions described in the first sections carry
residues crucial for activity. Our results allow a better under-
standing of the mode of action of this very important enzyme.
Given the similarity of the active sites and the high degree
of conservation between StSPL, Dpl1p and SPL (Figures 5C,
S1 and S2), the proposed mechanism can serve as basis for
further studies on the human counterpart.
In conclusion, this study provides the first structural character-
ization of a eukaryotic SPL, identifies critical residues for activity,
sheds light on the reaction mechanism, and demonstrates
the existence and functionality of a prokaryotic homolog of
the enzyme. Modulating the cofactor occupancy seems to be
a common feature of both StSPL and Dpl1p. Moreover, our
results allowed the generation of a high-quality homology model
of the human enzyme, pinpointing the conservation of the above
described residues. Most importantly, they provide a solid foun-
dation for structure-based drug design on SPL.EXPERIMENTAL PROCEDURES
Chemicals
All chemicals and reagents were of the highest commercially available grade.
Plasmid Constructs and Protein Expression and Purification
Plasmid construction and expression and purification of StSPL and Dpl1p
D1-102 are described in Supplemental Information.
Activity Assays
UV-visible spectra were recorded on a Cary-50 spectrophotometer (Varian)
using 1 cm light path quartz precision cells (Hellma). Protein concentration
was estimated using an average value of the extinction coefficient of a fully
reduced and a fully oxidized protein as calculated with ProtParam (Gasteiger
et al., 2005). The value used for FL WT StSPL was 790400 M-1cm-1 and
500500 M-1cm-1 for Dpl1p D1-102. S1P was purchased from Acros, Alexis
Biochemicals or Avanti Polar Lipids, while DHS1P and PS1P were from Avanti
Polar Lipids. The phosphosphingolipids were solubilized in 1% (w/v) Triton
X-100 (Fluka or Acros) to 1 mg/ml (corresponding to 2.6 mM). The suspension
was incubated at 37C for 30minwith 1min vortexing every 4min. After 10min
sonification and further vortexing, insoluble material was separated by a
10min centrifugation step at 14,0003 g at room temperature. Protein concen-
tration in the cell was set at 22 mM (1.2 mg/ml), for a total volume of 100 ml.
Seventy microliters of phosphosphingolipid solution was added to the protein
and briefly homogenized with a pipette. The buffer corresponded to the SEC
buffer containing 1 mM KPi. Spectra were recorded every minute from
500 to 320 nm until no or only slight spectral changes could be observed.
The yeast synthetic lethality test was carried out as described in Mukhopad-
hyay et al. (2008).
Semicarbazide (Fluka) was mixed to FL WT StSPL set at 14 mM to a molar
excess of 100-fold over active sites and spectra were recorded as describedStructure 18, 1054–above. After 1 hr incubation, S1P was added and the spectra recorded as
described above.
ForMSactivity assay,S1PcleavagebyStSPLwascarried out under thesame
conditions as the spectrophotometric activity assay except that S1P was solu-
bilized in 100% ethanol. The reaction mixture was desalted using C18 ZipTip
pipettes tips (Millipore) and diluted in 50% acetonitrile, 0.2% formic acid (pH
2)before injection.Massesweremeasured in thepositivemodeonaquadrupole
mass spectrometer equipped with an electrospray (ESI) ionization source and
a time of flight (TOF) ion separation device (Q-TOFUltima API,Waters Corpora-
tion). Multiple-charged protein ion signals were deconvoluted to produce zero-
charge spectra using theMaximumEntropyTM1 (MaxEnt1) algorithm in theMi-
cromass MassLynx software package (Thermo Scientific).Protein Crystallization and Structure Determination
Native StSPL and Dpl1p were crystallized by vapor diffusion (sitting drop) at
20C. For cocrystallization with PE, StSPL K311A (7 mg/ml) was incubated
for 10 min on ice with an equimolar amount of PLP. StSPL K311A and PE
(Fluka) at a 10-fold molar excess over protein subunit were then incubated
overnight at 4C and concentrated prior to crystallization. Bright yellow (struc-
tures St_1, St_2 and Dpl1p), pale yellow (structure St_3) or colorless (structure
St_4) crystals appeared after 2–15 days. Crystallization conditions are listed in
Table S2. Crystals were cryoprotected by adding ethylene glycol (EG) to the
well solution (which, in cocrystallization experiments, was supplemented
with the corresponding compound at the appropriate concentration)
(Table S2). Crystals were flash-frozen by rapid immersion in liquid propane.
Data sets were collected at 100K at the X06SA beamline of the Swiss Light
Source (SLS; Villigen, Switzerland). Data were processed with XDS (Kabsch,
1993). The first structure of StSPL (code St_2) was solved by molecular
replacement with Phaser (McCoy, 2007) using a polyserine dimer of GadB
(PDB entry 2DGK) as search model. FL WT StSPL set at 3 mg/ml was cocrys-
tallized with semicarbazide according to the same procedure as for PE omit-
ting the initial incubation with PLP and with 45 min incubation at 4C prior to
crystallization.Crystallographic Refinement and Validation
Refinement was carried out with CNS (Bru¨nger et al., 1998) and Phenix (Zwart
et al., 2008). The structure of Dpl1p D1-102 was solved with Phaser (McCoy,
2007) using a refined dimeric model of StSPL K311A (Bourquin, 2010). NCS
restraints were employed by default and manually edited during refinement,
unless data resolution was high enough to render them superfluous (Table 1).
Models were rebuilt with Coot (Emsley and Cowtan, 2004) and validated with
ProCheck (Laskowski et al., 1993) and MolProbity (Davis et al., 2007). PDB
entry codes are 3MAD (St_1), 3MAF (St_2), 3MAU (St_3), 3MBB (St_4), and
3MC6 (Dpl1p).Modeling of SPL and of StSPL K311A in Complex with S1P
A dimeric homology model of the folded core of SPL was computed based on
the structure of Dpl1pD1-102 using the programModeller 9v6 (Sali, 1995). The
PLP cofactor was also included in the calculation as a rigid-body residue. The
model, including the internal aldimine linkage of the cofactor with K353, was
geometry minimized with Phenix (Zwart et al., 2008).
A tentative model of StSPL K311A containing the external aldimine interme-
diate with the substrate S1P was prepared with Coot based on the structure of
St_3 (Figure S1C). The S1P ligand was obtained from PDB entry 3I9G (Wojciak
et al., 2009), manually coupled with PLP and optimized with the PRODRG
server (http://davapc1.bioch.dundee.ac.uk/prodrg/). The S1P hydrophobic
chain was positioned such that it interacts with a hydrophobic region encom-
passing residues L128*, Y249, L344*, Y345*, F346*, V496, L497, and F500. The
model was energy-minimized with Phenix.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at
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